Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
LOADING
|||
Switch Symbol:
Revenue Scaling
Trending higher, above historical average, strong compound growth.
Left:
||||
Total revenue from sales of goods and services
Latest
$829.45M
↑ 371% above average
Average (9y)
$175.97M
Historical baseline
Range
High:$829.45M
Low:$158333.00
CAGR
+159.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | $829.45M | +23258.2% |
| 2024 | $3.55M | -98.5% |
| 2023 | $240.74M | -1.0% |
| 2022 | $243.23M | +75.9% |
| 2021 | $138.29M | +57.2% |
| 2020 | $87.99M | -47.9% |
| 2019 | $168.80M | +945.7% |
| 2018 | $16.14M | -48.6% |
| 2017 | $31.41M | +19736.5% |
| 2016 | $158333.00 | - |